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ABSTRACT
BONGERS, B. C., M. S. WERKMAN, H. G. M. ARETS, T. TAKKEN, and H. J. HULZEBOS. A Possible Alternative Exercise Test for
Youths with Cystic Fibrosis: The Steep Ramp Test. Med. Sci. Sports Exerc., Vol. 47, No. 3, pp. 485–492, 2015. Purpose: The steep
ramp test (SRT) can be used to provide an indication of exercise capacity when gas exchange measurements are not possible. This study
evaluated the clinical usefulness of the SRT in adolescents with cystic fibrosis (CF) and compared the physiological responses of the SRT
with the standard cardiopulmonary exercise test (CPET). Methods: Forty patients with CF (17 boys and 23 girls; mean T SD age, 14.7 T
1.7 years; forced expiratory volume in 1 s, 86% T 18% of predicted) performed an SRT and a CPET with respiratory gas analysis in a
randomized balanced design. Peak work rate (WRpeak), HRpeak, peak minute ventilation (V̇Epeak), and peak oxygen uptake (V̇O2peak)
were the main outcome measures. Results: Patients with CF attained values for absolute and relative WRpeak during the SRT of 82% T
14% and 92% T 14% of predicted. Nutritional status and degree of airway obstruction did not influence SRT performance. Significantly
higher values were attained for WRpeak during the SRT compared with those during the CPET (252 T 60 vs 174 T 46 W; P G 0.001),
whereas significantly lower values were achieved for HRpeak (168 T 14 vs 182 T 12 bpm; P G 0.001), V̇Epeak (59.2 T 19.5 vs 72.0 T
20.2 LIminj1; P = 0.006), and V̇O2peak (36.9 T 7.5 vs 41.5 T 7.6 mLIkg
j1Iminj1; P = 0.008). A strong correlation between WRpeak
attained at the SRT and the V̇O2peak achieved during the CPET was found (r = 0.822, P G 0.001). Conclusions: The SRT seems to be a
quick, convenient, and low-cost exercise test that is well-tolerated in patients with CF with mild-to-moderate airway obstruction. It provides
an indication of exercise capacity and can potentially be used when exercise testing using gas exchange measurements is not possible.
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M
any children and adolescents with cystic fibrosis
(CF) are reported to have significantly reduced
exercise capacity (8,22), indicated by reduced
peak oxygen uptake (V̇O2peak) values attained during a max-
imal cardiopulmonary exercise test (CPET). The reduced
exercise capacity in patients with CF seems to have a multi-
factorial cause (35), in which respiratory, cardiovascular,
and peripheral muscle functions are all reported as potential
exercise limiting mechanisms (1). Two decades ago, Nixon
et al. (29) reported significant association between exercise
capacity of children and adolescents with CF and survival
over 8 yr. Moreover, exercise capacity has been found to be
positively linked to quality of life in CF (14). In addition,
several studies have confirmed that physical activity and
exercise training have many health benefits for patients with
CF; it positively affects the transmembrane potential differ-
ence (20), airway mucus clearance (32), lung function on the
short and long term (33), and exercise capacity (23).
Therefore, physical activity and exercise training have
become increasingly important and widely accepted as cor-
nerstones of CF management. Nowadays, performing a CPET
is recommended for standard CF care and follow-up because
it provides the clinician with important diagnostic, prognos-
tic, evaluative, and functional information (30). Moreover,
performing a CPET is recommended before initiation of any
exercise training not only to monitor disease progression but
also to detect exercise-induced limitations and therefore to
provide patients with safe training recommendations (40).
Despite the clinical value of the CPET and the mentioned
recommendations, premature exercise termination (e.g., due
to a lack of motivation, pain, seat discomfort, and dyspnea)
often limits its clinical usefulness. In addition, many CF
centers currently do not perform CPET as an assessment tool
for therapeutic intervention (4,37) because they do not have
the equipment (metabolic cart) to directly measure V̇O2peak
(37). Because of these limitations, there is a need for less
sophisticated clinical exercise testing procedures that can
easily be applied in large clinics, do not put large burden on
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the cardiopulmonary system, and do not require respiratory
gas analysis. This might increase the use of clinical exercise
testing and exercise training in patients with CF.
Maximal and submaximal field tests not requiring respi-
ratory gas analysis have been used to predict exercise ca-
pacity (e.g., modified shuttle test, 6-min walk test, 3-min
step test). However, the 6-min walk test (25) and the 3-min
step test (28) were reported to provide limited information
relating to exercise capacity in children and adolescents with
CF. The modified shuttle test has been found to be a reliable
and valid field test in adult patients with CF (11,12). How-
ever, we identified no published studies addressing the va-
lidity and reliability of the modified shuttle test in children
and adolescents with CF. Moreover, this test may have a
ceiling effect when testing children and adolescents with CF
with only mild-to-moderate lung dysfunction. On the other
hand, the alternative 10-m shuttle walk test and the 20-m
shuttle run test were reported to be reproducible and valid
assessments of aerobic capacity in children and adolescents
with CF (36). The steep ramp test (SRT) is another simple
short-time incremental exercise test that does not require use
of respiratory gas analysis measurements. The SRT is com-
pleted on a cycle ergometer up to maximal exertion, and the
attained peak work rate (WRpeak) is its primary outcome
measure. This WRpeak at the SRT has been reported to pro-
vide an indication of exercise capacity in different (patient)
populations (6,13,27). In healthy children and adolescents,
the SRT has recently been found to be a reliable and valid
exercise test to predict V̇O2peak during which the burden on
the cardiopulmonary system was smaller compared with the
regular CPET (6). The latter might be advantageous for pa-
tients with CF who often suffer from evident dyspnea during
exercise. In addition, in children and adolescents with CF,
comparable V̇O2peak values were found during the CPET
and during the SRT (38).
These findings highlight the potential for the SRT as an
alternative for currently used exercise tests to provide infor-
mation concerning the exercise capacity of children and ado-
lescents with CF. Before implementing the SRT in standard
medical care, knowledge concerning SRT performance in
children and adolescents with CF is required. Moreover, it is
important to obtain information about the characteristics of
the SRT compared with the regular CPET in this patient
group. Therefore, the objectives of the current investigation
were 1) to evaluate the clinical usefulness of the SRT in ad-
olescents with CF, 2) to compare the physiological response
to the SRT in adolescents with CF with the response to
the regular CPET, and 3) to validate the prediction equation
to predict V̇O2peak with SRT performance, as established in
healthy children and adolescents, in adolescents with CF.
METHODS
Patients. Adolescents with CF between 11 and 18 yr of
age and treated in the CF center of the Wilhelmina Children’s
Hospital, University Medical Center Utrecht, were invited to
participate in the current study between January 2010 and
September 2011. Body mass, body height, lung function, and
exercise capacity were measured as part of routine assess-
ments during the annual check-up. All patients were free from
acute pulmonary or gastrointestinal exacerbation at the time of
testing. The testing procedures used in this study met the as-
sumptions for standard of practice for the routine care of pa-
tients with CF. Patients and their guardians provided approval
for inclusion of the data acquired from these procedures in
research studies. After evaluation, the medical ethical com-
mittee of the University Medical Center Utrecht determined
that inclusion of the data conformed to the regulations of the
Dutch CF Registration and that inclusion of the data in this
study met the ethical polices of the University Medical Center
Utrecht and the regulations of the Dutch government.
Anthropometric measures. Body mass (kg) and body
height (m) were determined using an electronic scale (Seca
203; Seca, Hamburg, Germany) and a stadiometer (Ulmer
Stadiometer; Prof. E. Heinze, Ulm, Germany) respectively.
Body mass index (BMI) was calculated as the body mass di-
vided by body height squared. SD scores were calculated for
height for age, body mass for age, body mass for height, and
BMI for age using Dutch normative values (34). The equa-
tion of Haycock et al. (18), validated in infants, children,
and adults, was used to obtain the patient’s body surface
area (BSA).
Spirometry and plethysmography. Spirometry and
plethysmography measurements were performed before ex-
ercise testing by qualified lung function technicians of the CF
center after bronchodilation with salbutamol (800Kg). Forced
vital capacity (FVC) and forced expiratory volume in 1 s (FEV1)
were obtained from flow–volume curves (Masterscreen; Jaeger,
Würzburg, Germany). FEV1 was also expressed as a per-
centage of FVC (Tiffeneau index). Residual volume (RV) and
total lung capacity (TLC) were determined in a body ple-
thysmograph (Master Laboratory System; Jaeger, Würzburg,
Germany). The RV was expressed as a percentage of TLC
(RV/TLC%) as well. The internationally used reference values
of Zapletal (41) were used to express lung function values as
percentage of predicted values.
Exercise testing. At least 20 min after bronchodilation
with salbutamol (800 Kg) for spirometry, all patients per-
formed a CPET and an SRT on an electronically braked
cycle ergometer (Lode Corival; Lode BV, Groningen, the
Netherlands). Seat height was adjusted to the child’s leg
length, and both exercise tests were completed in a random-
ized and counterbalanced manner to control for a potential
warming-up effect, with equal numbers of patients performing
the tests as either CPET–SRT or SRT–CPET. A 15-min re-
covery period was completed between the two exercise tests.
After the completion of both tests, the participants were asked
which exercise test they preferred. During both tests, HR was
determined via a 12-lead ECG (Cardioperfect; Accuramed
BVBA, Herk-de-Stad, Belgium) and peripheral oxygen satu-
ration (SpO2) at the index finger was measured by pulse ox-
imetry (Masimo Rad-8; Masimo Inc., Irvine, CA). Moreover,
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participants breathed through a face mask (Hans Rudolph,
Kansas City, MO) during the CPET and the SRT to perform
breath-by-breath respiratory gas analysis and volume mea-
surements using a respiratory gas analysis system (ZAN 600;
Accuramed BVBA, Herk-de-Stad, Belgium). Gas analyzers
were calibrated using gases of known concentration, whereas
the flow meter was calibrated using a 3-L syringe (Hans
Rudolph, Kansas City, MO). Minute ventilation (V̇E), V̇O2,
carbon dioxide production (V̇CO2), and RER were calculated
from conventional equations. Output from the flow meter
and gas analyzers were averaged over 10-s intervals and stored
for further use. Peak exercise parameters were defined as
the highest values achieved within the last 30 s before maxi-
mal exertion.
CPET. Before performing the CPET, patients rested until
all measured variables were stable. During the CPET, par-
ticipants started with 3 min of unloaded cycling, after which
WR was increased by 10, 15, or 20 WIminj1, depending on
the participant’s body height (G125 cm, between 125 and
150 cm, and 9150 cm, respectively) (9,15) in a ramplike
manner (2, 3, or 4 W per 12 s). Patients had to maintain a
pedaling frequency between 60 and 80 rpm. Peak exercise
was defined as the point at which there was a sustained drop
in pedaling frequency from 60 rpm despite strong verbal en-
couragement. A test was considered to be at or near the
maximal level if at least one of the following criteria was
met: HRpeak 9180 bpm or RER at peak exercise (RERpeak)
91.0 (2). To measure the exhaustiveness of the CPET, the
Children’s OMNI Scale of Perceived Exertion was used,
which has been validated in children (31). The scale starts
with ‘‘0,’’ indicating the child is ‘‘not tired at all,’’ and ends
with ‘‘10,’’ meaning that the child is ‘‘very, very tired.’’ The
patients had to fill out the OMNI scale before and directly
after the CPET to obtain a $OMNI score (posttest OMNI
score minus pretest OMNI score). Recently constructed Dutch
reference values (9) were used to express the attained WRpeak
and V̇O2peak during the CPET, performed according to the
Godfrey (15) protocol, as a percentage of predicted.
SRT. Participants rested until all measured variables were
stable. After a 3-min warm-up at 25 W, the SRT started by
applying resistance to the ergometer in a ramp-like manner (2,
3, or 4 W per 2 s), resulting in increments of 10, 15, or 20 W
per 10 s depending on the participant’s body height (G120 cm,
between 120 and 150 cm, and 9150 cm, respectively) (6). The
participant was instructed to maintain a pedaling frequency
between 60 and 80 rpm, and peak exercise was defined as the
point at which the pedaling frequency definitely dropped
from 60 rpm despite strong verbal encouragement. Peak effort
was confirmed when participants showed subjective signs of
intense effort (e.g., unsteady biking, sweating, facial flushing,
and clear unwillingness to continue despite encouragement).
Before and directly after the SRT, the participants had to fill
out the Children’s OMNI Scale of Perceived Exertion to
measure the exhaustiveness of the SRT ($OMNI score). The
attained WRpeak at the SRT was compared with Dutch norm
values (7) and expressed as percentage of predicted.
Statistical analysis. The Statistical Package for the So-
cial Sciences (SPSS, version 15.0; SPSS Inc., Chicago, IL) was
used analyze the data. Data are presented as mean values T
SD. Shapiro–Wilk tests were performed to confirm normal
distribution of the data. As appropriate, an independent-
samples t-test or its nonparametric equivalent, the Mann–
Whitney U test, was performed on the anthropometric and
the exercise variables to test for significant differences be-
tween boys and girls and between the SRT and the CPET.
Pearson correlation coefficients were calculated between the
attained WRpeak at the SRT and several anthropometric, lung
function, and exercise variables. To validate the equation
established in healthy children and adolescents to predict the
V̇O2peak attained at the CPET from SRT performance, the
absolute WRpeak attained at the SRT by the adolescents with
CF was used to predict their V̇O2peak reached at the CPET by
the following formula (6):
V̇O2peak ¼ 8:262WRpeak SRT
 
þ 177:096
in which ‘‘V̇O2peak’’ stands for the predicted V̇O2peak in mil-
liliters per minute and ‘‘WRpeak SRT’’ represents the WRpeak
attained at the SRT in W (R2 = 0.917; SEE, 237.4). A Bland–
Altman plot was constructed to validate this equation to pre-
dict V̇O2peak from SRT performance in adolescents with CF.
A P value G0.05 was considered statistically significant.
RESULTS
Forty-one patients were included. One 13-yr-old boy was
excluded from analysis because he did not meet the sub-
jective and objective criteria of peak performance at both
exercise tests because of lack of motivation. Participant char-
acteristics of the other 40 patients with CF are listed in Table 1
for boys (n = 17) and girls (n = 23) separately. There were
no significant differences between boys and girls concerning
age and anthropometric parameters. With a mean T SD
FEV1 of 86% T 18% of predicted and an RV/TLC% of
28% T 10%, the total group of adolescents with CF suffered
from mild-to-moderate airflow obstruction. Boys attained
significantly higher absolute FEV1 values and significantly
lower RV/TLC% values compared with girls.
All 40 patients terminated the CPET and the SRT be-
cause of voluntary exhaustion, without adverse effects. They
all met the subjective criteria of peak performance during
the CPET and the SRT, and all but one patient attained
an HRpeak 9180 bpm and/or an RERpeak 91.0 during the
CPET. The only patient that did not meet the latter criteria
had an FEV1 value of 45% of predicted and performed a
symptom-limited CPET because of dyspnea. Table 2 pre-
sents the results of the patients with CF at the CPET and
the SRT. They attained mean V̇O2peak per kilogram values
at the CPET of 93% of predicted. This indicates that, overall,
the adolescents with CF had an aerobic exercise capacity
within the normal range. Compared with Dutch norm values
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for SRT performance, adolescents with CF attained values
for absolute (252 T 60 W) and relative (5.0 T 0.8 WIkgj1)
WRpeak during the SRT that corresponded to 82% T 14%
and 92% T 14% of predicted, respectively. Percentage of
predicted values for WRpeak normalized for body mass were
significantly higher than absoluteWRpeak values, expressed as
a percentage of predicted (P G 0.001), because of the gener-
ally decreased body weight (Table 1).
During the SRT, significantly higher values were attained
for both absolute and relative WRpeak compared with the
CPET, whereas significantly lower values at the SRT com-
pared with the CPET were achieved for HRpeak, peak V̇E
(V̇Epeak), and V̇O2peak. The duration of the load phase of the
SRT protocol was on average 2 min and 10 s, which was
significantly shorter than the load phase of the CPET pro-
tocol that lasted for almost 9 min. All patients with CF in-
dicated that they favored performing an SRT over a CPET
when they were asked about their preferential maximal ex-
ercise test. This is confirmed by the objective fact that the
SRT received significantly lower values for exhaustiveness
($OMNI) than the CPET.
To examine SRT performance in adolescents with CF in
more detail, patients were divided on the basis of the degree
of airway obstruction, as follows: a mild group (FEV1,
Q80%; n = 26) and a moderate group (FEV1, G80%; n = 14)
(Fig. 1, left graph). No between-group differences were
found for age (14.5 T 1.7 vs 14.9 T 1.7 yr, P = 0.589), body
height (1.65 T 0.13 vs 1.64 T 0.08 m, P = 0.921), body mass
(50.5 T 10.1 vs 50.0 T 8.2 kg, P = 0.898), and BMI (18.3 T
1.5 vs 18.5 T 1.6 kgImj2, P = 0.726). Participants in the mild
group had significantly lower values for the RV/TLC% (24% T
7% vs 35% T 11%, P = 0.001). There were no between-group
differences in the attained absolute (83% T 15% vs 80% T 12%
of predicted) and relative (92% T 14% vs 91% T 14% of pre-
dicted) WRpeak at the SRT (Fig. 1, left graph).
Patients with CF were also divided in subgroups on the
basis of nutritional status, as follows: a group with a BMI for
age SD score greater than or equal to j1.00 (n = 31) and a
TABLE 1. Patient characteristics.
Boys (n = 17 (43%)) Girls (n = 23 (57%)) P Value
Clinical parameters
Age (yr) 15.1 T 2.1 11.2 to 18.1 14.3 T 1.2 11.8 to 16.9 0.198
CF mutation classa
Class I (n (%)) 4 (24) 6 (26) NA
Class II (n (%)) 9 (53) 14 (61) NA
Class III (n (%)) 1 (6) 0 (0) NA
Class IV (n (%)) 0 (0) 1 (4) NA
Class V (n (%)) 2 (12) 0 (0) NA
Unknown (n (%)) 1 (6) 2 (9) NA
PA colonizationb
Never (n (%)) 6 (35) 2 (9) NA
Free of infection (n (%))c 5 (29) 9 (39) NA
Intermittent (n (%))d 2 (12) 5 (22) NA
Chronic (n (%))e 4 (24) 7 (30) NA
CF-related diabetes (n (%)) 3 (18) 4 (17) NA
Pancreatic insufficiency (n (%)) 14 (82) 19 (83) NA
Anthropometric parameters
Body mass (kg) 51.5 T 10.3 36.0 to 70.2 49.4 T 8.8 30.0 to 63.4 0.493
Body mass for age SD scoref,g j0.53 T 0.57 j1.39 to 0.51 j0.38 T 0.99 j2.77 to 1.19 0.485
Body height (m) 1.67 T 0.14 1.46 to 1.87 1.62 T 0.09 1.39 to 1.78 0.211
Body height for age SD scoref,g j0.67 T 0.87 j1.86 to 0.84 j0.30 T 1.07 j2.80 to 1.69 0.345
BMI (kgImj2)g 18.2 T 1.3 16.6 to 20.2 18.6 T 1.7 15.2 to 20.8 0.411
BMI for age SD scoref j0.39 T 0.65 j1.44 to 1.10 j0.21 T 0.74 j1.96 to 0.66 0.405
BSA (m2)h 1.54 T 0.21 1.20 to 1.90 1.48 T 0.18 1.07 to 1.76 0.414
Lung function parameters
FEV1 (L) 3.15 T 1.07 1.31 to 5.32 2.52 T 0.69 1.33 to 3.91 0.043*
Percent of predictedi 91 T 18 45 to 118 83 T 17 51 to 112 0.169
FVC (L)j 3.73 T 1.00 2.16 to 5.51 3.21 T 0.67 1.71 to 4.42 0.083
Percent of predictedi,j 93 T 13 62 to 116 90 T 12 61 to 115 0.406
Tiffeneau index (%)j 80 T 11 61 to 99 79 T 9 64 to 93 0.761
Percent of predictedi,j 96 T 13 72 to 117 94 T 11 76 to 111 0.761
RV/TLC%g,k 24 T 11 11 to 57 31 T 8 17 to 46 0.011*
Data are presented as mean T SD, range, or n (%).
aBased on the classification of CF transmembrane conductance regulator alleles used by Green et al. (16).
bBased on the criteria of Lee et al. (24).
cFree of Pseudomonas aeruginosa in the last 12 months.
d
e50% of the samples were positive for Pseudomonas aeruginosa in the last 12 months.
e950% of the samples were positive for Pseudomonas aeruginosa in the last 12 months.
fCalculated using Dutch normative values (34).
gMann–Whitney U test.
hCalculated using the equation from Haycock et al. (18).
iCalculated using reference values from Zapletal (41).
jFVC was not determined in one boy and two girls (n = 16 for boys and n = 21 for girls).
kBody plethysmography was not performed in two boys and four girls (n = 15 for boys and n = 19 for girls).
*P G 0.05.
NA, not applicable.
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group with a BMI for age SD score less than j1.00 (n = 9)
(Fig. 1, right graph). No differences between both groups
were found for age (14.6 T 1.7 vs 14.9 T 1.7 yr, P = 0.636),
body height (1.65 T 0.11 vs 1.64 T 0.15 m, P = 0.873), body
mass (51.7 T 8.7 vs 45.4 T 10.5 kg, P = 0.072), FEV1 (89% T
16% vs 79% T 22% of predicted, P = 0.147), and RV/TLC%
(26% T 8% vs 34% T 14%, P = 0.154). Figure 1, right graph,
shows that adolescents with CF and a BMI for age SD score
greater than or equal to j1.00 attained significantly higher
values for absolute WRpeak at the SRT (85% T 12% vs 72% T
16% of predicted), whereas there was no between-group
difference when SRT performance was normalized for body
mass (91% T 12% vs 92% T 19% of predicted).
Moderate-to-strong correlations were found between SRT
performance (WRpeak) and some anthropometric variables
(age, r = 0.665; body height, r = 0.768; body mass, r = 0.746;
BSA, r = 0.760; with P G 0.001 for all coefficients), lung
function variables (absolute FEV1, r = 0.675; absolute FVC,
r = 0.703; and TLC, r = 0.669; with P G 0.001 for all co-
efficients), and CPET variables (WRpeak, r = 0.922; V̇O2peak,
r = 0.822; and V̇Epeak, r = 0.763; with P G 0.001 for all co-
efficients). Figure 2 depicts the strong linear relation between
the absolute WRpeak attained at the SRT and the
absolute V̇O2peak achieved during the CPET. A strong
correlation was also observed between the absolute WRpeak
achieved at the SRT expressed as a percentage of predicted
and the absolute WRpeak reached at the CPET expressed as a
percentage of predicted (r = 0.837, P G 0.001). Between the
relative WRpeak achieved at the SRT and the relative WRpeak
attained at the CPET, both expressed as a percentage of pre-
dicted, a slightly lower correlation coefficient was found (r =
0.775, P G 0.001).
As depicted in Figure 3, the Bland–Altman plot demon-
strates an average bias T 1.96 SD between the predicted and
the measured V̇O2peak of j175.4 T 309.6 mLImin
j1 in our
group of patients with CF. The limits of agreement were
+431.4 and j782.1 mLIminj1.
DISCUSSION
The current study evaluated the clinical usefulness of
the SRT in adolescents with CF and compared the physio-
logical response to the SRT with the response to the regular
CPET in this group. Moreover, the validity of the previously
published prediction equation to predict V̇O2peak with SRT
TABLE 2. CPET and SRT results.
CPET SRT Difference (%) P Value
Time (s)a 536 T 124 315 to 810 132 T 27 75 to 195 j75 G0.001*
WRpeak (W) 174 T 46 98 to 270 252 T 60 127 to 385 +45 G0.001*
Percent of predicted 87 T 16b 52 to 118 82 T 14c 44 to 105 j6 0.112
WRpeak/kg (WIkg
j1) 3.5 T 0.6 2.4 to 4.9 5.0 T 0.8 3.5 to 6.5 +43 G0.001*
Percent of predicted 95 T 15b 70 to 127 92 T 14c 67 to 117 j3 0.301
HRpeak (bpm) 182 T 12 148 to 206 168 T 14 130 to 195 j8 G0.001*
RERpeak
d 1.12 T 0.11 1.00 to 1.39 1.10 T 0.15 0.82 to 1.42 j2 0.600
V̇Epeak (LImin
j1) 72.0 T 20.2 33 to 126 59.2 T 19.5 17 to 126 j18 0.006**
Ventilatory reserve (%) 23 T 20 j21 to 57 37 T 20 j31 to 75 +61 0.005**
V̇O2peak/kg (mLIkg
j1Iminj1) 41.5 T 7.6 23.8 to 52.3 36.9 T 7.5 17.9 to 49.9 j11 0.008**
Percent of predicted 93 T 15b 56 to 122 NA NA NA
SpO2 drop (%)
d,e 2.1 T 2.4 j2 to 8 1.3 T 2.0 j1 to 7 j38 0.113
$OMNIf 6.7 T 2.2 2.0 to 10.0 5.5 T 2.3 0.0 to 9.0 j18 0.043***
Values are presented as mean T SD or range.
aDuration of the load phase of the protocol.
bCalculated using reference values from Bongers et al. (9).
cCalculated using reference values from Bongers et al. (7).
dMann–Whitney U test.
eSpO2 determination was invalid in three boys and two girls (n = 35).
f




V̇O2peak/kg, V̇O2peak normalized for body mass; WRpeak/kg, WRpeak normalized for body mass.
FIGURE 1—Subgroup analysis of SRT performance in children with CF. Subgroups are based on degree of airway obstruction (left graph) and
nutritional status (right graph). Data are presented as mean þ SD.
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performance was investigated in adolescents with CF. We
confirmed that the SRT is a feasible, short-time, incremental
exercise test up to maximal exertion in adolescents with CF.
They achieved values for absolute and relative WRpeak during
the SRT corresponding to 82% and 92% of predicted. The
WRpeak attained at the SRT correlated well with the V̇O2peak
achieved at the CPET. Perhaps, most importantly for this
population, we showed that the SRT is cardiopulmonary less
demanding compared with the regular CPET because signifi-
cantly lower HRpeak, V̇Epeak, and $OMNI values as well as
significantly higher values for the ventilatory reserve at peak
exercise were found.
A post hoc analysis was performed to examine the effect
of nutritional status and the degree of airway obstruction on
SRT performance. Results show that nutritional status does
not influence SRT performance when corrected for body
mass, as there was no significant difference in the attained
WRpeak at an equivalent body mass expressed as a percent-
age of predicted between the subgroups. Although body
mass was found to be a significant predictor of absolute SRT
performance, it would be interesting to examine the effect of
nutritional status on SRT performance after normalizing for
fat-free mass (FFM) because normalizing for body mass has
been reported to overestimate the work capacity in patients
with CF at the CPET. This can be explained by the greater
level of fat depletion in undernourished patients with CF,
resulting in higher proportion of FFM per unit of body mass
(17). From a physiological perspective, FFM, as an indicator
of muscle mass, would probably be a better indicator for
SRT performance. We already showed this in an earlier study
in healthy boys and girls, in which SRT performance was
found to be best correlated to FFM (r = 0.930 and r = 0.902,
respectively; P G 0.001 for both coefficients) (7).
The degree of airway obstruction was also found to have
no influence on SRT performance. There were no significant
differences in the attained absolute and relativeWRpeak values
between mildly and moderately obstructed patients with CF.
However, it is possible that severe airway obstruction does
limit SRT performance. Boas et al. (5) reported that the
degree of airway obstruction was not a significant predictor
of anaerobic exercise capacity, as measured during a Wingate
anaerobic test. The authors explained this by suggesting that
anaerobic exercise capacity is dependent on the anaerobic
characteristics of the exercising muscles and not on oxygen
transport. SRT performance also relies on anaerobic exercise
capacity. In fact, with significantly higher WRpeak values
(+45%) and significantly lower V̇O2peak values (j11%) com-
pared with the CPET found in the current study, it is clear that
the SRT requires a substantial part of anaerobic glycolysis for
energy production. This is in agreement with a recent study
(38) that also reported lower V̇O2 values at equal WR values
at the SRT compared with those at the CPET and may be
explained by the slower V̇O2 on-kinetics observed in steeper
ramp slopes, which are suggested to compromise the aerobic
contribution to total energy delivery (10). Because the SRT
requires a substantial part of anaerobic glycolysis for energy
production as compared with the CPET, it may result in
higher production of lactic acid (H+) and, consequently, in an
increase in V̇CO2 that augments ventilation and, therefore,
the sensation of dyspnea during recovery. The latter rationale
would make the SRT inappropriate for patients with severe
lung dysfunction who experience evident dyspnea. However,
a post hoc analysis of the recovery data after the SRT and
CPET revealed that there were no significant differences in
the recovery in the delta values of HR, RER, or V̇E measured
at 30 and 60 s after termination of the exercise tests (data not
shown). Nevertheless, being independent of lung function
combined with the lower cardiopulmonary burden at peak
exercise highlights the potential of the SRT to be a clinically
useful and less demanding alternative for currently used ex-
ercise tests in patients with CF.
Because of the relatively large contribution of anaerobic
energy use during the SRT, this test might also serve to
evaluate the effects of a high-intensity interval exercise
training (HIT) program. This is also where the SRT origi-
nates from. It was introduced to determine and optimize HIT
WR in adult patients with chronic heart failure (26,27).
HIT might be an effective and efficient training regimen in
children and adolescents with CF, especially in ventilatory-
limited patients (21). Indeed, it seems that the SRT is
FIGURE 3—Bland–Altman plot of the V̇O2peak at the CPET predicted
from SRT performance and the measured V̇O2peak attained at the CPET.
FIGURE 2—The linear relation between WRpeak attained at the SRT
and V̇O2peak attained at the CPET (R
2 = 0.676).
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cardiopulmonary less demanding compared with the regu-
lar CPET because significantly lower HRpeak, V̇Epeak, and
$OMNI values as well as significantly higher values for the
ventilatory reserve at peak exercise were found in the cur-
rent study. In addition, HIT might mimic the physical ac-
tivity preferences of children and adolescents because
children’s physical activity patterns are characterized by
short intense bursts of activity (3).
For daily clinical purposes, the SRT may be valuable as a
simple screening tool that provides an indication of exercise
capacity in children and adolescents with CF and mild-to-
moderate pulmonary disease. Normative values for SRT
performance are available for children and adolescents be-
tween 8 and 19 yr of age (7). Nevertheless, the SRT should
not be used as a substitute for the more complex CPET. It is
recommended to refer a child with reduced SRT perfor-
mance for a regular CPET to identify possible exercise-
limiting mechanisms. The equation that was established in
healthy children and adolescents to predict V̇O2peak at the
CPET from SRT performance was found to overestimate the
V̇O2peak reached at the CPET in adolescents with CF. This is
probably due to the fact that adolescents with CF were found
to have slower V̇O2 kinetics (19). In addition, in contrary to
what has been previously reported within our clinical exer-
cise laboratory (38), we found a significant difference in
V̇O2peak per kilogram between CPET and SRT. This incon-
sistent result could be explained by the counterbalanced
test sequence in the current study. Because a warming-up is
thought to influence V̇O2peak kinetics (39), warming-up ef-
fects for SRT performance are ruled out using this counter-
balanced sequence. Thereby, the significant difference in
V̇O2peak per kilogram we found in this study could be explained
by the more dominant oxidative metabolism of the CPET.
For future research, it would be interesting to examine
SRT performance normalized for FFM in children and ad-
olescents with CF, also in subgroups based on nutritional
status, lung function, and oxygen saturation level. Therefore,
it would also be interesting to examine the exact contribu-
tion of the oxidative metabolism and anaerobic glycolysis
during the SRT in children with CF compared with that in
their healthy peers. Further research is also needed to inves-
tigate whether the SRT could serve as a feasible alternative
for evaluating exercise capacity in patients with a ventilatory
limited exercise capacity who experience evident dyspnea
during exercise. Finally, it would be interesting to study the
responsiveness of SRT performance after HIT in children
with CF to evaluate whether the SRT can be used to deter-
mine training intensity and monitor training progress.
The current study has some limitations. Although the two
exercise tests were completed in a randomized and counter-
balanced manner and cardiopulmonary variables returned to
baseline values before the second exercise test, it is not sure
whether all patients had full physiological metabolic recovery
in 15 min. HR values before the start of the exercise test were
not significantly different between the CPET and the SRT
(103 T 13 vs 103 T 13 bpm; P = 0.865). It would therefore
be relevant to investigate possible warming-up effects of
both tests on each other, especially of the preceding CPET on
(aerobic) SRT performance. Moreover, mainly patients with
CF with mild-to-moderate airflow obstruction took part in
the study. For this reason, these findings cannot be applied to
patients with (other) severe lung disease. Nevertheless, the
current study sample is representative for the population of
patients with CF in a tertiary CF center.
CONCLUSIONS
The SRT seems to be a quick, simple, convenient, and low-
cost exercise test that does not require respiratory gas analysis.
Its primary outcome measure (WRpeak) is strongly correlated
to V̇O2peak measured during a traditional CPET in adolescents
with mild-to-moderate CF. The SRT was well-tolerated by
patients with CF and can potentially be used in settings where
exercise testing using gas exchange measurements is not pos-
sible. However, more studies are needed to confirm our data.
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